News
Patent Approval for Discovery Technology of Natural Pesticides
16 March 2009
TyraTech, Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health, announced today that it has received approval from the United States Patent Office for a patent (US # 10/832,022) for its method of identifying compounds and compositions for potentially controlling the activity of insects and other invertebrates.
The patent protects TyraTech's key technology which screens plant derived natural compounds such as essential oils to identify those that have pesticidal activity. The technology is incorporated into a platform that is also able to characterize combinations of these natural compounds that interact in a synergistic combination to produce highly potent and non-toxic insecticide and parasiticide products. The technology targets the specific biological receptors which are found in invertebrates but not in humans and animals. The technology forms the discovery basis of TyraTech's products for the human health, animal health and pesticide markets which total more than $32 billion globally.
The patent covers the use of TyraTech's screening technology in the US for a period of 20 years from 24 April 2003
For further information please contact:
| TyraTech Inc. Alan Reade, Executive Chairman www.tyratech.com |
1 (321) 409 - 7720 |
| Nomura Code Securities | |
| Charles Walker | +44 (0)20 7776 1200 |
| www.nomuracode.com |
Media enquiries:
| Buchanan Communications | |
| Mary-Jane Johnson / Lisa Baderoon/ Catherine Breen / Stasa Filiplic | +44 (0) 20 7466 5000 |
| www.buchanan.uk.com |
About TyraTech
TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $23 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.
TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.
TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.